Tags: Drug.

Efungumab (trade name Mycograb) is a drug developed by NeuTec Pharma (a subsidiary of Novartis) intended to treat invasive Candida infection in combination with amphotericin B.

ATC prefix
none
FDA UNII code
BM86P708HW

Loading...

This page contains content from the copyrighted Wikipedia article "Efungumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.